KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Other Operating Expenses (2019 - 2025)

GoodRx Holdings' Other Operating Expenses history spans 7 years, with the latest figure at $119.2 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 4.71% year-over-year to $119.2 million; the TTM value through Dec 2025 reached $474.4 million, down 2.16%, while the annual FY2025 figure was $470.2 million, 2.12% down from the prior year.
  • Other Operating Expenses for Q4 2025 was $119.2 million at GoodRx Holdings, up from $118.4 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $152.5 million in Q4 2023 and bottomed at -$41.7 million in Q3 2022.
  • The 5-year median for Other Operating Expenses is $118.2 million (2024), against an average of $82.9 million.
  • The largest annual shift saw Other Operating Expenses plummeted 134.34% in 2021 before it skyrocketed 7834.74% in 2023.
  • A 5-year view of Other Operating Expenses shows it stood at $131.1 million in 2021, then plummeted by 101.5% to -$2.0 million in 2022, then surged by 7834.74% to $152.5 million in 2023, then fell by 17.97% to $125.1 million in 2024, then dropped by 4.71% to $119.2 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Other Operating Expenses are $119.2 million (Q4 2025), $118.4 million (Q3 2025), and $117.9 million (Q2 2025).